FDA approves Lilly's Mounjaro to reduce cardiovascular risk in type 2 diabetes patients
2 sources·Updated August 28, 2026
Read it better in the app
Every story, every source, in one clean feed — with breaking-news alerts, offline reading and dark mode. Free.
Download on theApp StoreAndroid — coming soon
